|
Suppliers for CAS
540737-29-9
|
Properties | | CAS |
540737-29-9 | | Formula |
C16H20N6O1 |
|
|
24 Registered suppliers
Aecochem Corp.
P.R.China
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
More details are to be found here
Sancai Industry Co.,Ltd.
P.R.China
More details are to be found here
H&Z Industry Co.,Ltd
P.R.China
More details are to be found here
Xingrui Industry Co., Limited
P.R.China
More details are to be found here
Hangzhou Meite Industry Co., Ltd (Hangzhou Meite Chemical Co., Ltd)
P.R.China
More details are to be found here
Capot Chemical Co., Ltd.
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C16H20N6O.C6H8O7
Molecular Weight: 504.497
WGKGermany: 3
HS Code: 29335990
Chemvon Biotechnology Co. Ltd.
P.R.China
Molecular Formula: C16H20N6O.C6H8O7
Molecular Weight: 504.497
WGKGermany: 3
HS Code: 29335990
Guangzhou Topwork Chemical Co., Ltd.
P.R.China
Molecular Formula: C16H20N6O.C6H8O7
Molecular Weight: 504.497
WGKGermany: 3
HS Code: 29335990
Wuhan PharmChem Co., LTD.
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
Shandong Ench Chemical Co.,Ltd
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
JieJie Group Co., Ltd.
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
Shandong Minglang Chemical Co., Ltd
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
Aea.ltd
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
Hangzhou Zhongqi Chem Co., Ltd
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
Hangzhou Lingrui Chemical Co., Ltd.
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
Skyrun Industrial Co., Ltd.
P.R.China
EINECS :638-826-4
Molecular formula :C16H20N6O•C6H8O7
BOC Sciences
USA
Description : Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: - Molecular Weight :504.5
- Melting Point :198-202 °C (dec.)
- Purity :0.99
Molecular Formula : C22H28N6O8 Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChI :
InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1
InChIKey :
SYIKUFDOYJFGBQ-YLAFAASESA-N
Solubility :
In Vitro: DMSO : ≥ 122.5 mg/mL (242.82 mM) H2O : 5 mg/mL (9.91 mM; Need ultrasonic and warming)
Appearance :
White to Off-white Solid
Application :
Janus Kinase Inhibitors
Storage : Powder: 3 years -20°C In solvent: 2 years -80°C
Synonyms :
CP-690550; CP 690550; CP690550; Tofacitinib; tasocitinib.
https://www.bocsci.com/product/tofacitinib-citrate-cas-540737-29-9-461917.html
More details are to be found here
Shandong SanYoung Industry Co., Ltd
P.R.China
Description : Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: - Molecular Weight :504.5
- Melting Point :198-202 °C (dec.)
- Purity :0.99
Molecular Formula : C22H28N6O8 Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChI :
InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1
InChIKey :
SYIKUFDOYJFGBQ-YLAFAASESA-N
Solubility :
In Vitro: DMSO : ≥ 122.5 mg/mL (242.82 mM) H2O : 5 mg/mL (9.91 mM; Need ultrasonic and warming)
Appearance :
White to Off-white Solid
Application :
Janus Kinase Inhibitors
Storage : Powder: 3 years -20°C In solvent: 2 years -80°C
Synonyms :
CP-690550; CP 690550; CP690550; Tofacitinib; tasocitinib.
https://www.bocsci.com/product/tofacitinib-citrate-cas-540737-29-9-461917.html
More details are to be found here
Carbone Scientific Co., Ltd.
U.K.
Description : Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: - Molecular Weight :504.5
- Melting Point :198-202 °C (dec.)
- Purity :0.99
Molecular Formula : C22H28N6O8 Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChI :
InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1
InChIKey :
SYIKUFDOYJFGBQ-YLAFAASESA-N
Solubility :
In Vitro: DMSO : ≥ 122.5 mg/mL (242.82 mM) H2O : 5 mg/mL (9.91 mM; Need ultrasonic and warming)
Appearance :
White to Off-white Solid
Application :
Janus Kinase Inhibitors
Storage : Powder: 3 years -20°C In solvent: 2 years -80°C
Synonyms :
CP-690550; CP 690550; CP690550; Tofacitinib; tasocitinib.
https://www.bocsci.com/product/tofacitinib-citrate-cas-540737-29-9-461917.html
More details are to be found here
Stereokem
USA
Description : Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: - Molecular Weight :504.5
- Melting Point :198-202 °C (dec.)
- Purity :0.99
Molecular Formula : C22H28N6O8 Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChI :
InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1
InChIKey :
SYIKUFDOYJFGBQ-YLAFAASESA-N
Solubility :
In Vitro: DMSO : ≥ 122.5 mg/mL (242.82 mM) H2O : 5 mg/mL (9.91 mM; Need ultrasonic and warming)
Appearance :
White to Off-white Solid
Application :
Janus Kinase Inhibitors
Storage : Powder: 3 years -20°C In solvent: 2 years -80°C
Synonyms :
CP-690550; CP 690550; CP690550; Tofacitinib; tasocitinib.
https://www.bocsci.com/product/tofacitinib-citrate-cas-540737-29-9-461917.html
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: - Molecular Weight :504.5
- Melting Point :198-202 °C (dec.)
- Purity :0.99
Molecular Formula : C22H28N6O8 Canonical SMILES : CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChI :
InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1
InChIKey :
SYIKUFDOYJFGBQ-YLAFAASESA-N
Solubility :
In Vitro: DMSO : ≥ 122.5 mg/mL (242.82 mM) H2O : 5 mg/mL (9.91 mM; Need ultrasonic and warming)
Appearance :
White to Off-white Solid
Application :
Janus Kinase Inhibitors
Storage : Powder: 3 years -20°C In solvent: 2 years -80°C
Synonyms :
CP-690550; CP 690550; CP690550; Tofacitinib; tasocitinib.
https://www.bocsci.com/product/tofacitinib-citrate-cas-540737-29-9-461917.html
More details are to be found here
|
_Co_Ltd_1_575.jpg){kind=logo}
details
details
details